$10 Billion Deal, page-13241

i dont think youre completely across what Im saying.

I think youre right in so far as this will go Ph 3 for broad use, I think youre ignoring Gritstone to say we have to be Ph 3 to strike a deal. Look again its suggested in the quarterly as well as AR.

What Im questioning is is this able to get a path to market for critical care with strong 11s? Not sure if you read post but that parh doesn't require approval. As far as Im aware and as management has suggested, we are the only opton for this approach. If thats life saving and without material safety issues, its going to get a start with 650k deaths annually right?

At what price point?

DYOR